Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT03997422
What this trial is testing

Hepatic Energy Fluxes in NASH and NAS Patients

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNASOverweight or Obesity+2 more
University of Minnesota 30
Not applicableUnknownNCT04887766
What this trial is testing

Study on GS300 on NAFLD

Who this might be right for
Nonalcoholic Fatty LiverWeight Loss
Gelesis, Inc. 250
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Not applicableUnknownNCT01544751
What this trial is testing

Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Prof Antonino Belfiore 150
Testing effectiveness (Phase 2)Study completedNCT04767529
What this trial is testing

Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 128
Not applicableNot Yet RecruitingNCT06757348
What this trial is testing

Fatty Liver and Pancreatic Steatosis

Who this might be right for
Exocrine Pancreatic InsufficiencyFatty Liver, NonalcoholicPancreatic Steatosis
Maria Marta Piskorz 61
Early research (Phase 1)Study completedNCT04709913
What this trial is testing

Multiple Ascending Dose Study of HU6 in High BMI Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Rivus Pharmaceuticals, Inc. 30
Not applicableUnknownNCT05037890
What this trial is testing

Effects of Plant Sterols and Stanols on Liver Inflammation

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Maastricht University Medical Center 8
Not applicableStudy completedNCT01030484
What this trial is testing

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Who this might be right for
Liver Disease
Johns Hopkins Bloomberg School of Public Health 2,501
Early research (Phase 1)Looking for participantsNCT07128797
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)NASH (Nonalcoholic Steatohepatitis)
Tasly Biopharmaceuticals Co., Ltd. 32
Not applicableNot Yet RecruitingNCT07168551
What this trial is testing

Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients

Who this might be right for
HyperuricemiaNAFLD (Nonalcoholic Fatty Liver Disease)Liver Fibrosis
Assiut University 111
Not applicableUnknownNCT05802199
What this trial is testing

Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 300
Large-scale testing (Phase 3)Ended earlyNCT02548351
What this trial is testing

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Intercept Pharmaceuticals 2,477
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Not applicableStudy completedNCT04820556
What this trial is testing

Gut Microbiota in Chronic Noncommunicable Diseases

Who this might be right for
Arterial HypertensionAtherosclerosis Occlusive DiseaseHeart Failure With Preserved Ejection Fraction+5 more
National Medical Research Center for Therapy and Preventive Medicine 1,084
Testing effectiveness (Phase 2)Study completedNCT02654977
What this trial is testing

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

Who this might be right for
Familial Partial LipodystrophyNonalcoholic SteatohepatitisNAFLD
University of Michigan 11
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Not applicableStudy completedNCT02962297
What this trial is testing

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH (Non-Alcoholic Steatohepatitis)
Zhejiang Medicine Co., Ltd. 120
Not applicableUnknownNCT02717000
What this trial is testing

NASH: Non-invasive Diagnostic Markers and Imaging

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Maastricht University Medical Center 110
Not applicableUnknownNCT01638832
What this trial is testing

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Johann Wolfgang Goethe University Hospital 572
Next Page